LINDSEY ALDRIDGE: Open Payments
NPI 1871221242 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $134 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $169 |
| Lilly USA, LLC | 3 | $64 |
| Novo Nordisk Inc | 3 | $53 |
| Amgen Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: UBRELVY, MOUNJARO, Ozempic, ZENPEP, QULIPTA, VRAYLAR, OTEZLA, SHINGRIX.
Industry payments across MO — which companies pay providers there.
